Greg Renza
Analyst, Truist
Replay available
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) Q1 2026 earnings conference call, held 2026-04-29. Replay captured from the company's public earnings webcast.

Analyst, Truist
Chief Commercial Officer
Chief Medical Officer and Head of Research and Development
Analyst, Cantor
Chief Executive Officer
Analyst, TD Calvin
Analyst, Bank of America
Watch the replay and follow the connected company analysis, news, and investor updates for Agios Pharmaceuticals, Inc..
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04260-ba42-7ab3-9c9a-bff430a9e7bc Created: 2026-08-27T08:40:32.307Z Duration: 2904.32 Channels: 1 00:00:00.000 -- 00:00:02.800 Joining us to discuss Agios Pharmaceuticals' 00:00:02.800 -- 00:00:05.279 first quarter twenty twenty six financial results and 00:00:05.279 -- 00:00:06.320 business highlights. 00:00:06.560 -- 00:00:08.720 You can access the slides for today's call 00:00:08.720 -- 00:00:10.719 by going to the Investors section of our 00:00:10.719 -- 00:00:12.480 website, agios.com. 00:00:13.065 -- 00:00:15.464 Please note we'll be making certain forward looking 00:00:15.464 -- 00:00:16.585 statements today. 00:00:16.904 -- 00:00:19.465 Actual events and results could differ materially from 00:00:19.465 -- 00:00:21.785 those expressed or implied by any forward looking 00:00:21.785 -- 00:00:22.505 statements 00:00:22.664 -- 00:00:25.864 because of various risks, uncertainties and other factors, 00:00:26.440 -- 00:00:28.520 including those set forth in our most recent 00:00:28.520 -- 00:00:30.120 filings with the SEC 00:00:30.200 -- 00:00:32.040 and any other future filings that we may 00:00:32.040 -- 00:00:33.320 make with the SEC. 00:00:34.040 -- 00:00:35.960 On the call with me today from AGIO 00:00:35.960 -- 00:00:38.520 are Brian Goff, Chief Executive Officer 00:00:39.035 -- 00:00:41.755 Cecilia Jones, Chief Financial Officer 00:00:41.915 -- 00:00:45.115 Sveta Milanova, Chief Commercial Officer and Doctor. Sarah 00:00:45.115 -- 00:00:47.835 Huynh, Chief Medical Officer and Head of Research 00:00:47.835 -- 00:00:48.715 and Development. 00:00:49.195 -- 00:00:51.435 Following prepared remarks, we will open the call 00:00:51.435 -- 00:00:51.915 for questions. 00:00:52.400 -- 00:00:54.079 With that, ...